N/A N=100 HIV Self-testing With Online Supervision for Vietnamese MSM
HIV
Primary: HIV Self-testing With Online Supervision Past 6 Months at Baseline — 50; 44 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=225 HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women
HIV
Primary: Number of Participants With HIV Viral Load Suppression in Plasma — 2; 1; 84; 8 Participants
N/A N=96 Addressing Psychosocial Needs and HIV Risk in Indian MSM
HIV/STI Risk · HIV/STI Incidence
Primary: Changes in HIV Risk Taking Behavior - Number of Condomless Sex Acts Per Participant — 7.58; 3.69 number of unprotected sex acts — p=<.001
N/A N=200 Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men
Human Papillomavirus
Primary: HPV Prevalence — 61 participants
N/A N=154 Young Men and Media Study
Sexual Behavior
Primary: Study Feasibility Based on the Overall Recruitment Rate — 36.5 overall recruitment rate
N/A N=636 Addressing the Continuum of Care Among High-risk Thai Men
HIV/AIDS · STD
Primary: Prevalence of HIV Testing in the Past 6 Months Among YMSM at Baseline — 92; 48 Participants
N/A N=609 Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination
Anus Neoplasms
Primary: Willingness to Receive the Human Papillomavirus (HPV) Vaccine — 338 Participants
N/A N=40 mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
HIV Infections · Sexually Transmitted Diseases, Viral · Syphilis
Primary: The Number of Participants Who Are Able to Self-administer the DPP® HIV-Syphilis Test With mLab App Plus — 12 Participants
Phase 3 N=575 Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women
HIV Infections
Primary: Time to the First New Persistent Infection of HPV 6, 11, 16, or 18 — 1.90; 1.04; 2.92; 2.05 Years — p=0.350
N/A N=115 Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)
HIV
Primary: Retention in the Cohort — 88; 84; 87 Participants
Phase 2 N=30 Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM
Substance Abuse · HIV Infections
Primary: Feasibility: Proportion of Persons Screened Who Are Eligible and Enrolled — 30 Eligible persons screened who enrolled
N/A N=54 Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Human Immunodeficiency Virus
Primary: Number of Participants With PrEP Adherence — 45 Participants
N/A N=673 ANCHORS Study: UH2 Project
HIV-1-infection
Primary: Quantity of Alcohol Consumption — 11.38; 7.81; 4.78 drinks
N/A N=118 Mobile-health (mHealth) Intervention to Support HIV Self-testing and PrEP Uptake Among Young Men Who Have Sex With Men
Human Immunodeficiency Virus
Primary: Number of Participants With Self-reported Self-administration of HIV Testing — 46; 44 Participants
N/A N=901 Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men
HIV · Gonorrhea · Chlamydia
Primary: Participants Self-Reporting Condomless Anal Sex at Baseline and 3 Months — 304; 312; 148; 184 Participants — p=0.20
Phase 2 N=200 An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
HIV Infection
Primary: Number of Participants With Serum Creatinine Event of Grade 1 or Higher — 1 Participants
N/A N=423 The Blued+ Combination HIV Prevention Pilot Study in China
Pre-Exposure Prophylaxis
Primary: Feasibility of Blued+ in China — 193; 316 Participants
N/A N=121 Enhancing Partner Services Among Men Who Have Sex With Men Living With HIV
Contact Tracing
Primary: Percentage of MSM Index Cases That Respond to the Follow-up Survey at 3 Months After Enrollment — 92.6; 82.5 percentage of participants
Phase 2 N=58 Pre-Exposure Prophylaxis in YMSM
HIV
Primary: Actual Number of Study Visits Completed by 24 Weeks — 3.5927; 4.6263; 4.6374 Visits — p=0.6983
N/A N=658 HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)
HIV Infections
Primary: PrEP Uptake — 2.764; 2.116; 2.104; 1.837 events per 1000 person-months
N/A N=108 Mhealth for PrEP Adherence by Young Adult MSM, Phase 2
Hiv
Primary: Wilson Self-reported Medication Adherence Scale — 77.48; 71.59 score on a scale
N/A N=2,665 Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
HIV Infection
Primary: Frequency of HIV Testing by Internet-recruited MSM. — 777; 215 Participants
Phase 2 N=60 Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Substance Abuse · HIV Infections
Primary: Change in Number of Positive Methamphetamine Urine Tests, Comparing Baseline (Week 0) to Final Visit (Week 12). — 40; 6 Percentage reduction
N/A N=811 eTest: Real-time, Remote Monitoring System for Home-based HIV Testing Among High-risk Men Who Have Sex With Men
HIV Infections
Primary: Model Adjusted Probability of Any HIV Testing — 57.0; 91.0; 89.4 percent probability
N/A N=60 Understanding and Reducing HIV Risk Behavior and Substance Use Among Self-identified Bisexual Adolescent Men
HIV/AIDS · Substance Use · Bisexuality
Primary: Retention — 25; 26 Participants
N/A N=600 Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men
HIV Infections · Sexually Transmitted Diseases · Sexual Behavior
Primary: Confidence to Engage in HIV Prevention Behaviors When Engaging in Receptive Anal Sex Over Time — 1.72; 1.71; 1.73; 1.72 units on a scale
N/A N=63 PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
Risk Reduction
Primary: Number of Participants Indicating the Intervention Was Acceptable — 37 Participants
N/A N=1,181 Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men
Human Immunodeficiency Virus Infection · Sexually Transmitted Diseases
Primary: Self-reported Consistent Condom Use During Vaginal Intercourse in the Past 3 Months — 121; 103; 125; 93 Participants — p=.008
N/A N=180 Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Hazardous Drinking · HIV
Primary: Number of Alcoholic Drinks Consumed — 11.6; 7.2 drinks per week — p=.04
N/A N=1,014 GonoScreen: Efficacy of Screening STIs in MSM
Neisseria Gonorrhoeae Infection · Chlamydia Trachomatis Infection
Primary: Incidence Rate of Ng Plus Ct Detected at Any Site Whilst Individuals Are Screened vs. Not Screened — 0.155; 0.205 Ng or CT cases per study visit